UBS Group’s CryoPort, Inc. Warrants CYRXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-900
| Closed | -$24K | – | 8810 |
|
|
2020
Q2 | $24K | Sell |
900
-175
| -16% | -$3.37K | ﹤0.01% | 6450 |
|
|
2020
Q1 | $15K | Buy |
1,075
+33
| +3% | +$477 | ﹤0.01% | 6705 |
|
|
2019
Q4 | $14K | Sell |
1,042
-20
| -2% | -$234 | ﹤0.01% | 7124 |
|
|
2019
Q3 | $14K | Sell |
1,062
-1,500
| -59% | -$25.1K | ﹤0.01% | 6978 |
|
|
2019
Q2 | $38K | Sell |
2,562
-571
| -18% | -$7.24K | ﹤0.01% | 6154 |
|
|
2019
Q1 | $30K | Buy |
3,133
+2,518
| +409% | +$19.2K | ﹤0.01% | 5956 |
|
|
2018
Q4 | $6K | Sell |
615
-309
| -33% | -$2.6K | ﹤0.01% | 7512 |
|
|
2018
Q3 | $9K | Buy |
924
+100
| +12% | +$1.12K | ﹤0.01% | 7237 |
|
|
2018
Q2 | $10K | Sell |
824
-300
| -27% | -$2.21K | ﹤0.01% | 7161 |
|
|
2018
Q1 | $6K | Sell |
1,124
-3,300
| -75% | -$17.9K | ﹤0.01% | 7186 |
|
|
2017
Q4 | $24K | Buy |
+4,424
| New | +$19.7K | ﹤0.01% | 6424 |
|
|
2017
Q2 | – | Sell |
-900
| Closed | -$1K | – | 8162 |
|
|
2017
Q1 | $1K | Buy |
900
+500
| +125% | +$432 | ﹤0.01% | 7506 |
|
|
2016
Q4 | $0 | Sell |
400
-2,370
| -86% | -$1.57K | ﹤0.01% | 8179 |
|
|
2016
Q3 | $1K | Sell |
2,770
-5,560
| -67% | -$2.71K | ﹤0.01% | 7565 |
|
|
2016
Q2 | $6K | Sell |
8,330
-2,050
| -20% | -$1.21K | ﹤0.01% | 7069 |
|
|
2016
Q1 | $6K | Buy |
10,380
+6,780
| +188% | +$3.74K | ﹤0.01% | 6952 |
|
|
2015
Q4 | $2K | Hold |
3,600
| – | – | ﹤0.01% | 8061 |
|
|
2015
Q3 | $2K | Buy |
+3,600
| New | +$2.9K | ﹤0.01% | 8125 |
|
UBS Group's CYRXW Position: Q3 2020 in Review
UBS Group sold out of CryoPort, Inc. Warrants (CYRXW) in Q3 2020, closing a stake of 900 shares — an estimated $24K sold.
UBS Group first reported a position in CYRXW in Q3 2015 and held it in 18 quarters. The position peaked at $38K in Q2 2019. 0 funds tracked by Wall St. Rank hold CYRXW as of Q3 2020.
- UBS Group reported no remaining CryoPort, Inc. Warrants position as of Q3 2020 after selling out during the quarter.
- UBS Group sold 900 CryoPort, Inc. Warrants shares in Q3 2020, an estimated $24K.
- UBS Group first reported a position in CryoPort, Inc. Warrants in Q3 2015 and held it in 18 quarters.
- UBS Group's CryoPort, Inc. Warrants position peaked at $38K in Q2 2019.
- 0 funds tracked by Wall St. Rank held CryoPort, Inc. Warrants as of Q3 2020.
Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.